BioSpace News Archive

PartsSource and Nuvolo today announced a strategic partnership that will offer professionals in healthcare technology management (HTM) access to 4 million medical replacement products and clinical service resources via integration inside Nuvolo’s modern, cloud-based Clinical Enterprise Asset Management (CMMS) platform to seamlessly manage the entire lifecycle of medical equipment.

Surescripts named five electronic health records (EHR) companies as prestigious 2018 Surescripts White Coat Award™ winners.

LifeScan, Inc., a world leader in blood glucose monitoring, revealed its latest innovation—the OneTouch Verio Reflect™ blood glucose meter—as part of a symposium on the future of connected self-monitoring of blood glucose at the European Association for the Study of Diabetes (EASD) 2018 annual meeting today.

W.L. Gore & Associates, Inc. (“Gore”), a global materials science company, plans to commercially launch the GORE™ ImproJect™ Plunger for Pre-Filled Syringes at the 2018 PDA’s Universe of Pre-Filled Syringe and Injection Device meeting in Orlando, FL on October 8th. Gore will be in Booth 313 at the event, to be held at the Loews Royal Pacific.

Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) today announced that Health Canada has granted market authorization of RADICAVA™ (edaravone) as an intravenous infusion treatment for amyotrophic lateral sclerosis (ALS), a rapidly progressive, neurodegenerative disease.1,2

Spinal Singularity announced that the company was awarded a Phase II SBIR grant from the National Institute of Health (NIH)

Alpha Source Group, a collective of three premier service companies including Alpha Source, Medical Optics and BC Technical, has hired Vionnta Rivers as chief commercial officer, effective Oct. 1.

Advent Access (Advent), one of Singapore’s most innovative medtech companies with a focus in end stage renal disease management, today announced that it has acquired the global manufacturing and commercialization rights to the Vwing™ Vascular Needle Guide product line and other key assets from Vital Access (the Acquisition), a vascular technology company headquartered in the US.

Disruption of the refill of patients’ regular combination inhaled corticosteroid therapy brand may have impacted symptoms and disease control and potentially lead to an increased rate of costly exacerbations and hospitalizations.

Milliman, Inc., a premier global consulting and actuarial firm today announced that it has been selected as a vendor for MassHealth’s Delivery System Reform Incentive Payment (DSRIP) Technical Assistance (TA) program and the MA DSRIP TA Marketplace.